Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fermagate vs Sevelamer in Haemodialysis Patients
NCT00844662Phase 3Terminated
- Sponsor
- INEOS Healthcare Limited
- Start
- Jul 2009
- Primary completion
- Sep 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of fermagate in hyperphosphatemia, sponsored by INEOS Healthcare Limited. Started Jul 2009; status: terminated.
02
Drugs
fermagate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00844662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844662.